News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Successfully Completes Tender Offer for Shares of Encysive Pharmaceuticals (ENCY) and Announces Subsequent Offer Period


4/1/2008 8:43:07 AM

NEW YORK--(BUSINESS WIRE)--Pfizer Inc (NYSE:PFE - News) announced today that Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer, has purchased all of the shares validly tendered and not withdrawn pursuant to its tender offer for all of the outstanding shares of common stock of Encysive Pharmaceuticals Inc. (NASDAQ: ENCY - News) at a purchase price of $2.35 per share, net to the seller in cash, without interest thereon and less any required withholding taxes.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES